Skip to content
10-Q

Quarterly Report

CHECKPOINT THERAPEUTICS, INC.

0001410578-24-001885

← back to feed
Filed
Nov 12, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2024 · Sep 30, 2024 43.15M sh
Shares Diluted Q3 2024 · Sep 30, 2024 37.56M sh
Shares Diluted Q3 2024 · Sep 30, 2023 19.99M sh
Shares Diluted Q3 2024 · Sep 30, 2023 15.84M sh
Shares Outstanding Q3 2024 · Sep 30, 2024 45.1M sh
Shares Outstanding Q3 2024 · Dec 31, 2023 27.04M sh
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$23.92M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$40.76M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $4.7M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $4.93M
Stockholders Equity Q3 2024 · Sep 30, 2024 −$12.59M
Stockholders Equity Q3 2024 · Jun 30, 2024 −$15.75M
Stockholders Equity Q3 2024 · Dec 31, 2023 −$13.05M
Stockholders Equity Q3 2024 · Sep 30, 2023 −$19.04M
Stockholders Equity Q3 2024 · Jun 30, 2023 −$23.27M
Stockholders Equity Q3 2024 · Dec 31, 2022 −$19.48M
Current Liabilities Q3 2024 · Sep 30, 2024 $17.77M
Current Liabilities Q3 2024 · Dec 31, 2023 $18.43M
Total Liabilities Q3 2024 · Sep 30, 2024 $17.77M
Total Liabilities Q3 2024 · Dec 31, 2023 $18.43M
Current Assets Q3 2024 · Sep 30, 2024 $5.18M
Current Assets Q3 2024 · Dec 31, 2023 $5.38M
Total Assets Q3 2024 · Sep 30, 2024 $5.18M
Total Assets Q3 2024 · Dec 31, 2023 $5.38M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.23
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.73
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.29
Eps Diluted Q3 2024 · Sep 30, 2023 −$2.07
Eps Basic Q3 2024 · Sep 30, 2024 −$0.23
Eps Basic Q3 2024 · Sep 30, 2024 −$0.73
Eps Basic Q3 2024 · Sep 30, 2023 −$0.29
Eps Basic Q3 2024 · Sep 30, 2023 −$2.07
Sga Expense Q3 2024 · Sep 30, 2024 $3.36M
Sga Expense Q3 2024 · Sep 30, 2024 $8.04M
Sga Expense Q3 2024 · Sep 30, 2023 $2.24M
Sga Expense Q3 2024 · Sep 30, 2023 $6.81M
Rd Expense Q3 2024 · Sep 30, 2024 $6.37M
Rd Expense Q3 2024 · Sep 30, 2024 $19.34M
Rd Expense Q3 2024 · Sep 30, 2023 $5.5M
Rd Expense Q3 2024 · Sep 30, 2023 $35.27M
Net Income Q3 2024 · Sep 30, 2024 −$9.73M
Net Income Q3 2024 · Sep 30, 2024 −$27.34M
Net Income Q3 2024 · Sep 30, 2023 −$5.72M
Net Income Q3 2024 · Sep 30, 2023 −$32.72M
Operating Income Q3 2024 · Sep 30, 2024 −$9.72M
Operating Income Q3 2024 · Sep 30, 2024 −$27.35M
Operating Income Q3 2024 · Sep 30, 2023 −$7.7M
Operating Income Q3 2024 · Sep 30, 2023 −$41.98M
Revenue Q3 2024 · Sep 30, 2024 $41K
Revenue Q3 2024 · Sep 30, 2023 $31K
Revenue Q3 2024 · Sep 30, 2023 $97K